BioSpace News Archive

Capstan Therapeutics, Inc. announced the appointment of Ramin Farzaneh-Far, M.D., as Chief Medical Officer and the promotion of Miguel Arcinas to Senior Vice President, Corporate Development.

Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that the company will provide an overview of clinical and preclinical progress in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th at 9:00 AM Pacific Time.

Medable Inc. announces new intelligent automation technology applied across its clinical trials platform to cut standard trial build timelines by at least half.

Novotech announced that it will have the largest ever presence at the J.P.Morgan Healthcare Conference in San Francisco, CA, USA, January 8-11, 2024.

Vera Therapeutics, Inc. (Nasdaq: VERA) today announced it will host an in-person R&D day featuring Richard Lafayette, M.D., FACP, from Stanford University Medical Center.

NewAmsterdam Pharma Company N.V. announced the appointment of William H. Lewis, J.D., M.B.A., as Chair of its Board of Directors.

OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2024 at Westin St. Francis hotel in San Francisco.

Wave Life Sciences Ltd. announced key 2024 milestones across its clinical programs, growing pipeline, and leading RNA medicines platform.

Ardelyx, Inc. provided an update on the company’s progress in 2023 and initial expectations for 2024.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that it has acquired Boston Orthotics & Prosthetics, a leader in pediatric orthotic management for over 50 years.